Literature DB >> 22103751

Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses.

G J Crystal1, G Malik, S-H Yoon, S-J Kim.   

Abstract

BACKGROUND: We tested the hypothesis that an upregulation of antioxidant proteins [Cu-Zn superoxide dismutase (SOD), Mn SOD, catalase, glutathione peroxidase, and glutathione peroxidase] plays a role in the delayed protection against myocardial stunning produced by isoflurane preconditioning (ISOPC). Findings were compared with late ischemic PC (IPC).
METHODS: Fourteen mongrel dogs were chronically instrumented to measure coronary blood flow and myocardial wall thickening (WT) in conscious state. In Group 1, dogs underwent IPC, induced by a 10-min coronary artery occlusion (CAO); after 24 h of reperfusion, they were subjected to a second 10-min ischemia CAO-reperfusion. In Group 2 (ISOPC), dogs inhaled one minimum alveolar concentration (MAC) ISO (1.4% in O(2)) for 60 min, allowed to recover for 24 h, and then subjected to CAO ischemia-reperfusion. Recovery of WT following the initial 10-min CAO in Group 1 served as control response for both ISOPC and IPC. Expression and activity of antioxidant proteins were measured using Western blotting and spectrophotometric techniques, respectively.
RESULTS: Two to three hours of reperfusion were required for recovery of WT following either ISOPC or IPC; in contrast, without PC, WT remained markedly reduced (30% below baseline) at this time point and required more than 6 h of reperfusion for recovery. Neither IPC nor ISOPC affected expression of Cu-Zn SOD, Mn SOD, or catalase. However, ISOPC increased activity of Mn SOD (+40%), catalase (+39%), glutathione peroxidase (+37%), and glutathione reductase (+93%) (P < 0.05); IPC had similar effects.
CONCLUSION: ISOPC had powerful, delayed anti-stunning effect that was associated with an enhancement of endogenous antioxidant defenses.
© 2011 The Authors Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103751     DOI: 10.1111/j.1399-6576.2011.02583.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  13 in total

1.  Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes.

Authors:  Jun Liu; Shuangmei Yang; Xiaoran Zhang; Guoze Liu; Xiuqin Yue
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome.

Authors:  Bruce A Berkowitz; Jacob Lenning; Nikita Khetarpal; Catherine Tran; Johnny Y Wu; Ali M Berri; Kristin Dernay; E Mark Haacke; Fatema Shafie-Khorassani; Robert H Podolsky; John C Gant; Shaniya Maimaiti; Olivier Thibault; Geoffrey G Murphy; Brian M Bennett; Robin Roberts
Journal:  FASEB J       Date:  2017-06-07       Impact factor: 5.191

3.  Vascular aging and hemodynamic stability in the intraoperative period.

Authors:  Ferrante S Gragasin; Stephane L Bourque; Sandra T Davidge
Journal:  Front Physiol       Date:  2012-04-02       Impact factor: 4.566

4.  Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling.

Authors:  Hui Wang; Lei Wang; Nan-lin Li; Jun-tang Li; Feng Yu; Ya-li Zhao; Ling Wang; Jun Yi; Ling Wang; Jie-fang Bian; Jiang-hao Chen; Shi-fang Yuan; Ting Wang; Yong-gang Lv; Ning-ning Liu; Xiao-shan Zhu; Rui Ling; Jun Yun
Journal:  Oxid Med Cell Longev       Date:  2014-07-23       Impact factor: 6.543

5.  Age-related murine hippocampal CA1 laminae oxidative stress measured in vivo by QUEnch-assiSTed (QUEST) MRI: impact of isoflurane anesthesia.

Authors:  Bruce A Berkowitz; Robert H Podolsky; Karen Lins Childers; Alexander Gow; Brandy L Schneider; Scott C Lloyd; Kelly E Bosse; Alana C Conti; Robin Roberts; Ali M Berri; Emma Graffice; Kenan Sinan; Waleed Eliwat; Yimin Shen
Journal:  Geroscience       Date:  2020-01-25       Impact factor: 7.713

6.  The role of macrophage migration inhibitory factor in anesthetic-induced myocardial preconditioning.

Authors:  Andreas Goetzenich; Sandra Kraemer; Rolf Rossaint; Christian Bleilevens; Florian Dollo; Laura Siry; Setareh Rajabi-Alampour; Christian Beckers; Josefin Soppert; Hongqi Lue; Steffen Rex; Jürgen Bernhagen; Christian Stoppe
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

7.  A subanesthetic dose of isoflurane during postconditioning ameliorates zymosan-induced neutrophil inflammation lung injury and mortality in mice.

Authors:  Hui Wang; Jing Fan; Nan-lin Li; Jun-tang Li; Shi-fang Yuan; Jun Yi; Ling Wang; Jiang-hao Chen; Yong-gang Lv; Qing Yao; Ting Wang; Yu-cai Wang; Rui Ling
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

8.  Subanesthetic isoflurane relieves zymosan-induced neutrophil inflammatory response by targeting NMDA glutamate receptor and Toll-like receptor 2 signaling.

Authors:  Jun-Tang Li; Wei-Qi Wang; Ling Wang; Ning-Ning Liu; Ya-Li Zhao; Xiao-Shan Zhu; Qin-Qin Liu; Chun-Fang Gao; An-Gang Yang; Lin-Tao Jia
Journal:  Oncotarget       Date:  2016-05-31

9.  Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning.

Authors:  Britta Mayer; Josefin Soppert; Sandra Kraemer; Sabrina Schemmel; Christian Beckers; Christian Bleilevens; Rolf Rossaint; Mark Coburn; Andreas Goetzenich; Christian Stoppe
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

10.  Epithelial HO-1/STAT3 affords the protection of subanesthetic isoflurane against zymosan-induced lung injury in mice.

Authors:  Ling Wang; Ya-Li Zhao; Ning-Ning Liu; Xiao-Shan Zhu; Qin-Qin Liu; Hai-Yu Mei; Li-Feng Wang; An-Gang Yang; Chun-Fang Gao; Jun-Tang Li
Journal:  Oncotarget       Date:  2017-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.